FindTrial
Sign In

A prospective study of clinical and pathological characteristics of patients with gastro-esophageal cancers in sub-Himalayan region.

Clinico-pathological characteristics of the adult patients with gastro-esophageal cancers in a tertiary teaching hospital in a sub-himalayan region: A prospective descriptive study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/05/033487
Enrollment
50
Registered
2021-05-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C159- Malignant neoplasm of esophagus, unspecified Health Condition 2: C169- Malignant neoplasm of stomach, unspecified

Interventions

None listed

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age â?? more than 18 years. 2. Patients with histopathologically proven epithelial gastro-esophageal cancers. 3. Patients giving their informed consent for participation in the study.

Exclusion criteria

Exclusion criteria: 1. Patients with recurrent gastroesophageal cancers. 2. Patients not having requisite details. 3. Patients with benign or borderline tumors.

Design outcomes

Primary

MeasureTime frame
â?¢ To study the oncological profile of the patients with gastro-esophageal cancer â?? demographic characteristics, clinicoradiological features, histopathological types, immunohistochemical markers, and disease stage.Timepoint: 24 months—

Secondary

MeasureTime frame
To study the oncological profile of the patients with gastro-esophageal cancer â?? demographic characteristics, clinicoradiological features, histopathological types, immunohistochemical markers, and disease stage.Timepoint: 24 months—

Countries

India

Contacts

Public ContactSunil Kumar Singh

AIIMS, Rishikesh

dr.pankajgarg@gmail.com9868708542

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026